Established 1999
 
8,000 companies from
USA,Canada and India.		  
   
Search over 25,000 News & Earnings Archives    
 

AtheroGenics, Inc.(AGIX)

 
123Jump Rating: - Avoid   Underwriters: Chase H & Q
      Adams, Harkness & Hill, Inc.
Status: Priced   A.G. Edwards & Sons Inc.
 
Address: 8995 Westside Pkwy.
 FiledDate: 02/25/2000
  Alpharetta,
    
  GA 30004
 Filed Price Range ($): $11.00-13.00
       
Telephone: 678-336-2500 Filed Offer Amount ($ Million): $48.00
       
Fax: 678-336-2501 Shares Offered (Millions): 6
       
Websites: http://www.atherogenics.com Shares Outstanding (Millions): 23
       
Management: Michael Henos, Chair.
 IPO Date: 08/08/2000
  Russell Medford, Pres./CEO/Dir.
    
  Mark Colonnese, EVP
 Final Offer Price ($): $8.00
       
Industry: Biotech Final Offer Size (Millions of Shares): 6.00
       
Employees: 58 Final Offer Amount ($ Million): $48.00
       
Competitors: GlaxoSmithKline
 S-1 Forms:
  Novartis
    
  Tanox
  
       
     
     
     
       
 
- Avoid        - Value Gap        - Short-Term Growth        - Long-Term Growth        - Long-Term Value

Company Links
Executives Products Services
Income Data 
Year Revenues Costs Oper Income Taxes Net Income EPS
1995 0.00 1128.26 -1128.26 0.00 -1106.71 -.72
1996 0.00 2324.65 -2325.65 0.00 -2048.09 -1.1
1997 0.00 5644.7 -5644.7 0.00 -5159.31 -2.25
1998 0.00 10528.71 -10528.71 0.00 -10733.84 -4.45
1999 5791.65 11719.84 -5928.18 0.00 -5988.8 -2.45
 
 
350 Fund Managers Interviews - 10-year Annual earnings on 4,600 U.S. companies - 20-quarter Earnings on 3,800 U.S. companies - 3,200 U.S. IPO Prospectuses
- 2,100 Economic data releases from U.S., EU, UK, India, HK and Australia. 10-year Annual reports on 3,500 U.S. companies -
U.S. Earnings Calendar with 4,800 companies - 90,000 10-K reports - 26,000 Global markets news archive - 2,200 Earnings Conference Call Summaries
© 1999-2008 123jump.com. All rights reserved